NCT04240171View on ClinicalTrials.gov

Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

January 30, 2022

Study Completion Date

January 31, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Dapagliflozin 5Mg Tab

Dapagliflozin 5mg tablets daily

DRUG

Glimepiride 4Mg Tab

Glimepiride Tablets daily

Trial Locations (1)

31527

Tanta University Hospital, Tanta

All Listed Sponsors
collaborator

Tanta University

OTHER

lead

Damanhour University

OTHER

NCT04240171 - Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter